D.E. Shaw Boosts Stake in Medicis Pharmaceutical (MRX) Above 5%
More News related to MRX
- Facial Injectables Emerge From the Recession
- Medicis to Present at Piper Jaffray Annual Health Care Conference
- Piper Jaffray Upgrades Medicis Pharmaceutical (MRX) to Neutral; Gaining More Confidence
- Medicis to Present at Credit Suisse Annual Healthcare Conference
- Medicis (MRX) Reports Q3 EPS of $0.50, Beats by 8c; Guides Q4
In a 13G filing after the close on Medicis Pharmaceutical Corp. (NYSE: MRX), D.E. Shaw disclosed a 3,136,350 share, or 5.3%, stake in the company. D.E. Shaw held 1,963,933 MRX shares at the quarter ended 3/31/09. A 13G indicates a "passive investment" above 5%.
Medicis Pharmaceutical Corporation operates as a specialty pharmaceutical company in the United States and Canada.
Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php
Related Categories
13GsStocks Mentioned
+0.03Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
